Deutsche Bank
CNTX icon

Deutsche Bank’s Context Therapeutics CNTX Stock Holding History

Deutsche Bank’s Portfolio CNTX Stock Details CNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$23.8K Sell
79,422
-11,460
-13% -$5.65K ﹤0.01% 3541
2026
Q2 		$50K Buy
+90,882
New +$184K ﹤0.01% 3566

Other funds holding CNTX

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $530M AUM 95.29% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Clear Harbor Asset Management
Clear Harbor Asset Management Stamford, Connecticut $1.74B AUM 28.15% 1-Year Est. Return
Natixis
Natixis Paris, France $28B AUM 27.03% 1-Year Est. Return
Axxcess Wealth Management
Axxcess Wealth Management Carlsbad, California $2.44B AUM 16.42% 1-Year Est. Return

Deutsche Bank's CNTX Position: Q3 2026 in Review

Deutsche Bank reduced its Context Therapeutics (CNTX) stake by 13% in Q3 2026, selling an estimated $5.65K and leaving 79,422 shares worth $23.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3541.

Deutsche Bank first reported a position in CNTX in Q2 2026 and has held it in 2 quarters since. The position peaked at $50K in Q2 2026. 27 funds tracked by Wall St. Rank hold CNTX as of Q3 2026.

  • Deutsche Bank held 79,422 shares of Context Therapeutics worth $23.8K as of Q3 2026.
  • Deutsche Bank sold 11,460 Context Therapeutics shares in Q3 2026, an estimated $5.65K.
  • Context Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #3541 holding.
  • Deutsche Bank first reported a position in Context Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • Deutsche Bank's Context Therapeutics position peaked at $50K in Q2 2026.
  • 27 funds tracked by Wall St. Rank held Context Therapeutics as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.